<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Do You Have a Head of Social Media?</title>
	<atom:link href="http://blog.pharmexec.com/2010/04/30/do-you-have-a-head-of-social-media/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2010/04/30/do-you-have-a-head-of-social-media/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 14:53:10 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Don Crouse</title>
		<link>http://blog.pharmexec.com/2010/04/30/do-you-have-a-head-of-social-media/comment-page-1/#comment-71586</link>
		<dc:creator>Don Crouse</dc:creator>
		<pubDate>Thu, 06 May 2010 13:16:38 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=1568#comment-71586</guid>
		<description>Without guidance from the FDA to some extent everything pharma does with social media is an experiment.  Differing opinions reign because nobody knows for sure what really works and how or when the FDA might react to a particular social media activity.

I think a key takeaway from the blog post is be prepared for crissis.  With social media you are joining the conversation.  How do you react when the conversation goes down a periless path not anticipated?  Every pharmaceutical company needs a prepared plan for anticpating and handling the unexpected.  A knee jerk reaction can clearly have negative implications that spread quickly online and in the media.</description>
		<content:encoded><![CDATA[<p>Without guidance from the FDA to some extent everything pharma does with social media is an experiment.  Differing opinions reign because nobody knows for sure what really works and how or when the FDA might react to a particular social media activity.</p>
<p>I think a key takeaway from the blog post is be prepared for crissis.  With social media you are joining the conversation.  How do you react when the conversation goes down a periless path not anticipated?  Every pharmaceutical company needs a prepared plan for anticpating and handling the unexpected.  A knee jerk reaction can clearly have negative implications that spread quickly online and in the media.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

